155 related articles for article (PubMed ID: 37759224)
21. KIAA1429-mediated RXFP1 attenuates non-small cell lung cancer tumorigenesis via N6-methyladenosine modification.
Zhang Z; Guo J; Gong C; Wu S; Sun Y
Cancer Biomark; 2024 Feb; ():. PubMed ID: 38427468
[TBL] [Abstract][Full Text] [Related]
22. KIAA1429 is a potential prognostic marker in colorectal cancer by promoting the proliferation via downregulating WEE1 expression in an m6A-independent manner.
Ma L; Lin Y; Sun SW; Xu J; Yu T; Chen WL; Zhang LH; Guo YC; Wang YW; Chen T; Wei JF; Zhu LJ
Oncogene; 2022 Jan; 41(5):692-703. PubMed ID: 34819634
[TBL] [Abstract][Full Text] [Related]
23. N6-methyladenosine methyltransferase KIAA1429 promoted ovarian cancer aerobic glycolysis and progression through enhancing ENO1 expression.
Gan L; Zhao S; Gao Y; Qi Y; Su M; Wang A; Cai H
Biol Direct; 2023 Oct; 18(1):64. PubMed ID: 37807062
[TBL] [Abstract][Full Text] [Related]
24. Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma.
Hensel T; Giorgi C; Schmidt O; Calzada-Wack J; Neff F; Buch T; Niggli FK; Schäfer BW; Burdach S; Richter GH
Oncotarget; 2016 Jan; 7(2):1451-63. PubMed ID: 26623725
[TBL] [Abstract][Full Text] [Related]
25. Correlation NKX2.2 IHC and
Pasricha S; Pahwa S; Pruthi M; Jajodia A; Gupta G; Sharma A; Durga G; Kamboj M; Tiwari A; Panigrahi M; Mehta A
Indian J Pathol Microbiol; 2023; 66(1):58-62. PubMed ID: 36656211
[TBL] [Abstract][Full Text] [Related]
26. Cell cycle arrest and apoptosis are early events in radiosensitization of EWS::FLI1
Lin MY; Damron TA; Horton JA
Int J Radiat Biol; 2023; 99(10):1570-1583. PubMed ID: 36913323
[TBL] [Abstract][Full Text] [Related]
27. Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, "undifferentiated small round cell tumors". A clinicopathologic, immunophenotypic and molecular analysis.
Machado I; Yoshida A; Morales MGN; Abrahão-Machado LF; Navarro S; Cruz J; Lavernia J; Parafioriti A; Picci P; Llombart-Bosch A
Ann Diagn Pathol; 2018 Jun; 34():1-12. PubMed ID: 29661713
[TBL] [Abstract][Full Text] [Related]
28. The endochondral bone protein CHM1 sustains an undifferentiated, invasive phenotype, promoting lung metastasis in Ewing sarcoma.
von Heyking K; Calzada-Wack J; Göllner S; Neff F; Schmidt O; Hensel T; Schirmer D; Fasan A; Esposito I; Müller-Tidow C; Sorensen PH; Burdach S; Richter GHS
Mol Oncol; 2017 Sep; 11(9):1288-1301. PubMed ID: 28319320
[TBL] [Abstract][Full Text] [Related]
29. Prospective Clinical Genomic Profiling of Ewing Sarcoma:
Ogura K; Elkrief A; Bowman AS; Koche RP; de Stanchina E; Benayed R; Mauguen A; Mattar MS; Khodos I; Meyers PA; Healey JH; Tap WD; Hameed M; Zehir A; Shukla N; Sawyers C; Bose R; Slotkin E; Ladanyi M
JCO Precis Oncol; 2022 Aug; 6():e2200048. PubMed ID: 35952322
[TBL] [Abstract][Full Text] [Related]
30. Protein phosphatase 1 regulatory subunit 1A in ewing sarcoma tumorigenesis and metastasis.
Luo W; Xu C; Ayello J; Dela Cruz F; Rosenblum JM; Lessnick SL; Cairo MS
Oncogene; 2018 Feb; 37(6):798-809. PubMed ID: 29059150
[TBL] [Abstract][Full Text] [Related]
31. A novel HDGF-ALCAM axis promotes the metastasis of Ewing sarcoma via regulating the GTPases signaling pathway.
Yang Y; Ma Y; Gao H; Peng T; Shi H; Tang Y; Li H; Chen L; Hu K; Han A
Oncogene; 2021 Jan; 40(4):731-745. PubMed ID: 33239755
[TBL] [Abstract][Full Text] [Related]
32. Promotive role of USP29-mediated deubiquitination in malignant proliferation of colorectal cancer cells via the KIAA1429/SOX8 axis.
Li J; Yang J; Chen Z; Liu L; Wang H; Deng Q; Chen Y; Que Y; Fu Z
Biomol Biomed; 2023 May; 23(3):483-495. PubMed ID: 36373629
[TBL] [Abstract][Full Text] [Related]
33. p21-activated kinases as viable therapeutic targets for the treatment of high-risk Ewing sarcoma.
Qasim SL; Sierra L; Shuck R; Kurenbekova L; Patel TD; Rajapakshe K; Wulff J; Nakahata K; Kim HR; Landesman Y; Unger TJ; Coarfa C; Yustein JT
Oncogene; 2021 Feb; 40(6):1176-1190. PubMed ID: 33414491
[TBL] [Abstract][Full Text] [Related]
34. RNA sequencing and functional studies of patient-derived cells reveal that neurexin-1 and regulators of this pathway are associated with poor outcomes in Ewing sarcoma.
Roundhill EA; Chicon-Bosch M; Jeys L; Parry M; Rankin KS; Droop A; Burchill SA
Cell Oncol (Dordr); 2021 Oct; 44(5):1065-1085. PubMed ID: 34403115
[TBL] [Abstract][Full Text] [Related]
35. Circular RNA circ_KIAA1429 accelerates hepatocellular carcinoma progression via the miR-133a-3p/high mobility group AT-hook 2 (HMGA2) axis in an m6A-dependent manner.
Zhang CP; Huang XY
Hum Cell; 2023 Sep; 36(5):1741-1754. PubMed ID: 37368192
[TBL] [Abstract][Full Text] [Related]
36. EWS/ETS-Driven Ewing Sarcoma Requires BET Bromodomain Proteins.
Gollavilli PN; Pawar A; Wilder-Romans K; Natesan R; Engelke CG; Dommeti VL; Krishnamurthy PM; Nallasivam A; Apel IJ; Xu T; Qin ZS; Feng FY; Asangani IA
Cancer Res; 2018 Aug; 78(16):4760-4773. PubMed ID: 29898995
[TBL] [Abstract][Full Text] [Related]
37. N6-methyladenine- induced LINC00667 promoted breast cancer progression through m6A/KIAA1429 positive feedback loop.
Ren S; Zhang Y; Yang X; Li X; Zheng Y; Liu Y; Zhang X
Bioengineered; 2022 May; 13(5):13462-13473. PubMed ID: 36700472
[TBL] [Abstract][Full Text] [Related]
38. Abemaciclib Is Active in Preclinical Models of Ewing Sarcoma via Multipronged Regulation of Cell Cycle, DNA Methylation, and Interferon Pathway Signaling.
Dowless M; Lowery CD; Shackleford T; Renschler M; Stephens J; Flack R; Blosser W; Gupta S; Stewart J; Webster Y; Dempsey J; VanWye AB; Ebert P; Iversen P; Olsen JB; Gong X; Buchanan S; Houghton P; Stancato L
Clin Cancer Res; 2018 Dec; 24(23):6028-6039. PubMed ID: 30131386
[TBL] [Abstract][Full Text] [Related]
39. Targeting specificity protein 1 transcription factor and survivin using tolfenamic acid for inhibiting Ewing sarcoma cell growth.
Shelake S; Sankpal UT; Paul Bowman W; Wise M; Ray A; Basha R
Invest New Drugs; 2017 Apr; 35(2):158-165. PubMed ID: 28025760
[TBL] [Abstract][Full Text] [Related]
40. IL6 secreted by Ewing sarcoma tumor microenvironment confers anti-apoptotic and cell-disseminating paracrine responses in Ewing sarcoma cells.
Lissat A; Joerschke M; Shinde DA; Braunschweig T; Meier A; Makowska A; Bortnick R; Henneke P; Herget G; Gorr TA; Kontny U
BMC Cancer; 2015 Jul; 15():552. PubMed ID: 26215971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
